Observations

In a successful test of an innovative meeting format, the agency gathered feedback from the regulated community on cannabis sampling, cannabis testing, and lab proficiency testing.

No WSLCB board meeting this week + a second listen and learn forum on the Quality Assurance Testing and Product Requirements rulemaking project.

The Board discussed craft cannabis, representation of patient perspectives, and Portland’s equity program.

The committee discussed further delays on the next release of MJ Freeway’s Leaf Data Systems and alternative approaches to cannabis traceability.

Expect a revised launch date for Washington’s version of MJ Freeway’s Leaf Data Systems seed-to-sale traceability system, the information backbone of the I-502 regulated marketplace.

The team reviewed the first interagency meeting of the WSLCB’s Cannabis 2.0 project and assessed delays updating Washington State’s version of MJ Freeway’s Leaf Data Systems.

The Board adopted an interim policy on cannabinoid additives, heard a cannabis rulemaking timeline, and listened to public comment on the failings of the state traceability vendor, MJ Freeway.

The Board prepared to adopt a new interim policy on cannabinoid additives, discussed Cannabis 2.0, and reacted to Seattle Hempfest’s lawsuit.

Licensees should not expect to see the new release of Washington State’s version of MJ Freeway’s Leaf Data Systems this week.

A new packaging and labeling rulemaking project was initiated; a timeline for all open rulemaking projects was presented; and the Board heard calls to focus on medical cannabis and evidence-based rulemaking.